中国临床药理学杂志2011，Vol.27Issue(7)：533-539,7.
Mohnarin2009年度报告：中南地区细菌耐药监测
Mohnarin 2009 annual report:Bacterial ditribution and resistance surveillance in central - south China
李丽 1田磊 1张蓓 1朱旭慧 1陈中举 1王斌 1朱琴 1孙自镛1
作者信息
- 1. 华中科技大学同济医学院附属同济医院,武汉430030
- 折叠
摘要
Abstract
Objective To investigate the resistance of clinical isolates from central - south region of China to antimicrobial agents commonly used in 2009. Methods Disk diffusion susceptibility test was used to determine the antimicrobial susceptibility. Data was analyzed by Whonet 5.4 software. Results Of 48468 clinical isolates, 67. 1% was Cram -negative bacilli and 32. 7% was Cram - positive cocci. ESBLs were produced in 60.9% of E. Coli and 46. 8% of K. Pneumonia. Sixty point five percent of Staphylococcus aureus was MRSA and 62.9% of coagulase - negative Staphyloccus were methicillin - resistant. None of Staphylococcus aureus was resistant to vancomycin, teicoplanin and linezolid. One point four percent of coagulase - negative Staphyloccus were resitant to teicoplanin. None of coagulase - negative Staphyloccus were resitant to vancomycin and linezolid. Two point three percent of E.faecallis and 5.6% E-.faecium were resistant to vancomycin. One point four percent of E-.faecallis and 0.7% E.faecium were resistant to teicoplanin. None of them was resistant to linezolid. Zero point two percent of E. Coli,I. 2% of K. Pneumonia and 0. 8% E. Cloacae were resistant to Imipenem. Conclusion Enterobacteriaceae resistant to carbapenem, VRE and coagulase -negative Staphyloccus resistant to teicoplanin were produced. The control of the resistance of clinical isolates was austere.关键词
耐药性监测；抗菌药Key words
bacterial ditribution and resistance/antibacterial agents分类
医药卫生引用本文复制引用
李丽,田磊,张蓓,朱旭慧,陈中举,王斌,朱琴,孙自镛..Mohnarin2009年度报告：中南地区细菌耐药监测[J].中国临床药理学杂志,2011,27(7):533-539,7.
